Harbor Investment Advisory’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Harbor Investment Advisory’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.8K	Hold	150	–	–	﹤0.01%	964
2026 Q1	$15.6K	Hold	150	–	–	﹤0.01%	826
2025 Q4	$15.7K	Hold	150	–	–	﹤0.01%	860
2025 Q3	$13.9K	Hold	150	–	–	﹤0.01%	851
2025 Q2	$12K	Hold	150	–	–	﹤0.01%	859
2025 Q1	$13K	Hold	150	–	–	﹤0.01%	822
2024 Q4	$12.4K	Hold	150	–	–	﹤0.01%	825
2024 Q3	$13K	Hold	150	–	–	﹤0.01%	820
2024 Q2	$12.3K	Hold	150	–	–	﹤0.01%	816
2024 Q1	$12K	Hold	150	–	–	﹤0.01%	830
2023 Q4	$11.4K	Hold	150	–	–	﹤0.01%	816
2023 Q3	$10.9K	Hold	150	–	–	﹤0.01%	803
2023 Q2	$11.3K	Hold	150	–	–	﹤0.01%	1007
2023 Q1	$11.4K	Hold	150	–	–	﹤0.01%	1009
2022 Q4	$11.8K	Hold	150	–	–	﹤0.01%	992
2022 Q3	$11K	Hold	150	–	–	﹤0.01%	1028
2022 Q2	$11K	Hold	150	–	–	﹤0.01%	1019
2022 Q1	$12K	Hold	150	–	–	﹤0.01%	1033
2021 Q4	$12K	Hold	150	–	–	﹤0.01%	1027
2021 Q3	$12K	Hold	150	–	–	﹤0.01%	1032
2021 Q2	$12K	Hold	150	–	–	﹤0.01%	985
2021 Q1	$12K	Hold	150	–	–	﹤0.01%	954
2020 Q4	$11K	Hold	150	–	–	﹤0.01%	916
2020 Q3	$10K	Hold	150	–	–	﹤0.01%	854
2020 Q2	$10K	Hold	150	–	–	﹤0.01%	787
2020 Q1	$8K	Hold	150	–	–	﹤0.01%	791
2019 Q4	$10K	Buy	+150	New	+$9.13K	﹤0.01%	637

Other funds holding PJP

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Harbor Investment Advisory's PJP Position: Q2 2026 in Review

Harbor Investment Advisory held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 150 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #964.

Harbor Investment Advisory first reported a position in PJP in Q4 2019 and has held it in 27 quarters since. 63 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Harbor Investment Advisory held 150 shares of Invesco Pharmaceuticals ETF worth $17.8K as of Q2 2026.
Harbor Investment Advisory left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #964 holding.
Harbor Investment Advisory first reported a position in Invesco Pharmaceuticals ETF in Q4 2019 and has held it in 27 quarters since.
63 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.